Other disorders such as Parkinson's disease are associated with excessive activity in specific groups of neurons (Lobb, 2014) and could be candidates for treatment with an appropriate combination of potassium channel subtype and cell type-specific promoter. Here, KCNA3 is linked to Parkinson disease.